Electronic patient-reported outcomes with vital sign monitoring versus usual care during trastuzumab deruxtecan treatment for metastatic breast cancer: Updated results from the PRO-DUCE study.

Authors: Yuichiro Kikawa, Yukari Uemura, Tetsuhiko Taira, Chiyoe Kitagawa, Hideki Maeda, Hiroaki Kato, Naoki Hashimoto, Mitsuchika Hosoda, Yohei Hamanaka, Yuko Tanabe, Tatsuya Yoshida, Kaori Tane, Daisuke Takabatake, Takashi Ishikawa, Takayuki Iwamoto, Takeshi Yamaguchi, Daisuke Takiguchi, Hirofumi Mukai, Naruto Taira, Takafumi Sangai

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.1545

Source: Full article


Abstract

1545